Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1449188485
总结
CYP2C9 *3 is associated with increased likelihood of Blood Coagulation Disorders when treated with acenocoumarol in people with Atrial Fibrillation, Atrial Flutter or Venous Thrombosis as compared to CYP2C9 *1.